| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |